Joseph Mauro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joseph Mauro has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Arnav Rana
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
1 shared publication- Eduardo Solessio
Center for Vision Research, Department of Ophthalmology, State University of New York Upstate Medical University
1 shared publication - Frank A. Middleton
Department of Neuroscience and Physiology, State University of New York Upstate Medical University
1 shared publication Liam P Coyne
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
1 shared publication- Sanaea Bhagwagar
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
1 shared publication Xiaowen Wang
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (1) , e202603770
Mitochondrial protein import stress augments α-synuclein aggregation and neural damage
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because most mouse models of mitochondrial stress are confounded by bioenergetic defects. Here, we show that expression of Ant1 P.A114P,A123D , previously shown to cause mitochondrial protein import clogging in cultured human cells, does not affect the overall bioenergetic capacity, yet it induces proteostatic stress responses in the cytosol that suggests accumulation of unimported precursor proteins. In a Parkinson’s disease model expressing α-synuclein (A53T), Ant1 P.A114P,A123D increased the size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation, and worsened motor coordination defects. Importantly, we found no evidence of bioenergetic defects in either α-synuclein (A53T) or α-synuclein (A53T) + Ant1 P.A114P,A123D mice. These data suggest that Ant1 P.A114P,A123D likely induces mitochondrial protein import stress, and contributes to neural damage through cytosolic proteostatic stress and altered aggregation dynamics of neuropathogenic proteins independent of bioenergetics.
- 10 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (1) , e202603770
Open AccessMitochondrial protein import stress augments α-synuclein aggregation and neural damage
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because most mouse models of mitochondrial stress are confounded by bioenergetic defects. Here, we show that expression of Ant1 P.A114P,A123D , previously shown to cause mitochondrial protein import clogging in cultured human cells, does not affect the overall bioenergetic capacity, yet it induces proteostatic stress responses in the cytosol that suggests accumulation of unimported precursor proteins. In a Parkinson’s disease model expressing α-synuclein (A53T), Ant1 P.A114P,A123D increased the size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation, and worsened motor coordination defects. Importantly, we found no evidence of bioenergetic defects in either α-synuclein (A53T) or α-synuclein (A53T) + Ant1 P.A114P,A123D mice. These data suggest that Ant1 P.A114P,A123D likely induces mitochondrial protein import stress, and contributes to neural damage through cytosolic proteostatic stress and altered aggregation dynamics of neuropathogenic proteins independent of bioenergetics.